Baebies
Durham
About Baebies
Baebies was founded in 2014 by Richard West and Vamsee Pamula, following the successful development of digital microfluidics technology, the development and launch of multiple products, and the eventual sale of Advanced Liquid Logic to Illumina, Inc. Baebies has now licensed its core technology, acquired product and manufacturing assets, and built seasoned management and technical teams to pursue opportunities in newborn screening and near-patient diagnostic testing. Baebies newborn screening platform, SEEKER, is FDA authorized and CE marked. The FINDER and FINDER 1.5 platforms are CE marked and the FINDER 1.5 SARS-CoV-2 test received emergency use notification from the FDA. Baebies’ digital microfluidics technology is a recipient of multiple awards, including the coveted Disruptive Technology Award from AACC in their ‘search for the next innovative testing solution that will transform patient care Baebies' mission is to save lives and make lives better by bringing new technologies, new tests, and new hope to newborns, patients, and healthcare professionals worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $119.8M
- Last round: Series Unknown (May 2022)
- Website: baebies.com
- Phone: (844) 244-4034
Industries & Categories
Hospital, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/baebies-123198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.